Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China flag China · Delayed Price · Currency is CNY
54.00
-1.56 (-2.81%)
Nov 17, 2026, 3:04 PM CST

SHE:002653 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
6,0584,3883,7213,3553,0152,773
Revenue Growth
41.87%17.91%10.92%11.27%8.72%-16.71%
Gross Profit
4,6813,1212,6602,3842,0901,826
Operating Income
1,277199.62262.03331.58141.5737.6
Net Income
1,304259.58395.46295.11277.07345.06
Earnings Per Share
1.150.230.350.270.260.32
EPS Growth
275.82%-34.29%29.63%3.85%-18.75%-45.76%

Revenue by Segment

Fiscal Year
FY 2025
Period EndingDec '25
Sichuan Hisun Corporation Merger
530.58
Parent Company
4,397
Intersegment Effect
-4,497
Liaoning Hisun
548.14
Shenyang Hisun
287.23
Tibet Pharmaceuticals Merger
2,553
Tibet Haize
534.79
Total
4,354

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
2,7521,3861,2061,329775.39575.11
Total Debt
2,2691,9801,9101,8072,1111,249
Net Cash (Debt)
483.79-593.2-704.22-477.74-1,336-674.16
Net Cash Growth
------
Net Cash Per Share
0.43-0.53-0.62-0.44-1.25-0.63

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
1,448786442.05449.5894.5535.8
Capital Expenditures
-354.85-331.98-440.65-391.01-700.17-702.94
Free Cash Flow
1,093454.031.3958.57-605.62-667.14
Free Cash Flow Growth
380.96%32537.74%-97.63%---

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
77.27%71.14%71.47%71.05%69.31%65.86%
Operating Margin
21.07%4.55%7.04%9.88%4.70%1.36%
Pretax Margin
21.61%6.24%12.44%9.02%12.16%18.42%
Profit Margin
21.52%5.92%10.63%8.80%9.19%12.44%
FCF Margin
18.04%10.35%0.04%1.75%-20.09%-24.06%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.5260.2670.4150.200-0.185
Dividend Per Share Growth
0%-35.66%107.50%---50.22%
Dividend Yield
0.97%0.54%1.31%0.82%-0.93%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
46.90219.3193.2786.5685.5263.02
Forward PE
45.3791.9258.2062.9969.5362.77
P/FCF Ratio
55.26125.3826513.18436.15--
PS Ratio
9.9712.979.917.617.867.84